≥2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level Mean Ca level/dose No. of Cases Total N ** Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI/SE/SD ** P between groups *** P for trend ****
17311057 Gale 2008 atopic eczema at 9 mo Quartile 1:<30 nmol/L 9 440 crude OR 1.0
Quartile 2: 30–50 10 440 1.11 0.43–2.84
Quartile 3: >50–75 15 440 1.75 0.73–4.17
Quartile 4: >75 14 440 1.62 0.67–3.89

Duplicate one row per exposure category or intervention group.

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: F-K

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.